These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 18215696

  • 1. Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease.
    Wang D, Strandgaard S, Borresen ML, Luo Z, Connors SG, Yan Q, Wilcox CS.
    Am J Kidney Dis; 2008 Feb; 51(2):184-91. PubMed ID: 18215696
    [Abstract] [Full Text] [Related]

  • 2. Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension.
    Wang D, Strandgaard S, Iversen J, Wilcox CS.
    Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R195-200. PubMed ID: 18685064
    [Abstract] [Full Text] [Related]

  • 3. Elevated asymmetric dimethylarginine is associated with oxidant stress aggravation in patients with early stage autosomal dominant polycystic kidney disease.
    Raptis V, Georgianos PI, Sarafidis PA, Sioulis A, Makedou K, Makedou A, Grekas DM, Kapoulas S.
    Kidney Blood Press Res; 2013 Feb; 38(1):72-82. PubMed ID: 24577239
    [Abstract] [Full Text] [Related]

  • 4. Exercise capacity in polycystic kidney disease.
    Reinecke NL, Cunha TM, Heilberg IP, Higa EM, Nishiura JL, Neder JA, Almeida WS, Schor N.
    Am J Kidney Dis; 2014 Aug; 64(2):239-46. PubMed ID: 24787761
    [Abstract] [Full Text] [Related]

  • 5. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML.
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [Abstract] [Full Text] [Related]

  • 6. Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease.
    Kocyigit I, Yilmaz MI, Orscelik O, Sipahioglu MH, Unal A, Eroglu E, Kalay N, Tokgoz B, Axelsson J, Oymak O.
    Nephron Clin Pract; 2013 Jun; 123(3-4):157-64. PubMed ID: 23887359
    [Abstract] [Full Text] [Related]

  • 7. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
    Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.
    Diabetes Care; 2004 Mar; 27(3):765-9. PubMed ID: 14988299
    [Abstract] [Full Text] [Related]

  • 8. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
    Sydow K, Hornig B, Arakawa N, Bode-Böger SM, Tsikas D, Münzel T, Böger RH.
    Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
    [Abstract] [Full Text] [Related]

  • 9. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease.
    Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, Frölich JC.
    Circulation; 1997 Apr 15; 95(8):2068-74. PubMed ID: 9133517
    [Abstract] [Full Text] [Related]

  • 10. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease.
    Kielstein JT, Böger RH, Bode-Böger SM, Frölich JC, Haller H, Ritz E, Fliser D.
    J Am Soc Nephrol; 2002 Jan 15; 13(1):170-176. PubMed ID: 11752034
    [Abstract] [Full Text] [Related]

  • 11. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.
    Kielstein JT, Böger RH, Bode-Böger SM, Schäffer J, Barbey M, Koch KM, Frölich JC.
    J Am Soc Nephrol; 1999 Mar 15; 10(3):594-600. PubMed ID: 10073610
    [Abstract] [Full Text] [Related]

  • 12. Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease.
    Wang D, Iversen J, Wilcox CS, Strandgaard S.
    Kidney Int; 2003 Oct 15; 64(4):1381-8. PubMed ID: 12969157
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The role of asymmetric dimethylarginine in the regulation of nitric oxide level in rats with acute renal injury].
    Sukhovershin RA, Gilinskiĭ MA.
    Ross Fiziol Zh Im I M Sechenova; 2012 Apr 15; 98(4):497-505. PubMed ID: 22834339
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Endothelial dysfunction and oxidative stress in polycystic kidney disease.
    Klawitter J, Reed-Gitomer BY, McFann K, Pennington A, Klawitter J, Abebe KZ, Klepacki J, Cadnapaphornchai MA, Brosnahan G, Chonchol M, Christians U, Schrier RW.
    Am J Physiol Renal Physiol; 2014 Dec 01; 307(11):F1198-206. PubMed ID: 25234311
    [Abstract] [Full Text] [Related]

  • 19. Nitric oxide synthase inhibitors and hypertension in children and adolescents.
    Goonasekera CD, Rees DD, Woolard P, Frend A, Shah V, Dillon MJ.
    J Hypertens; 1997 Aug 01; 15(8):901-9. PubMed ID: 9280214
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.